Atlas Trials

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT06141980 · UNKNOWN

Trial details

NCT number
NCT06141980
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
T2DM (Type 2 Diabetes Mellitus)
Start date
2023-12-01
Primary completion
2025-09-01
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.